Barbiturates in Peru: not individually verified
Also known as: barbs
We have not confirmed that Barbiturates specifically is scheduled in Peru, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.
- What is on record
- Not confirmed. This row is a class label and the class cannot be resolved member by member here, because the member by member check was run against the 88 substance slugs this corpus carries and returned no member to check: there is no phenobarbital, secobarbital, amobarbital or butalbital row in the set. What can be said about the class is what Peru's schedule says. Anexo N. 2 of the Reglamento approved by Decreto Supremo 023-2001-SA carries twelve barbiturates in Lista III B, at Allobarbital item 1, Amobarbital item 2, Aprobarbital item 3, Barbital item 4, Butalbital item 6, Ciclobarbital item 7, Hexobarbital item 10, Metabarbital item 12, Pentobarbital item 14, Secbutabarbital item 15, Secobarbital item 16 and Vinilbital item 17, and carries four in Lista III C, at Barbital item 1, which is the same substance as Lista III B item 4, Fenobarbital item 4, Metilfenobarbital item 7 and Tiopental item 9, so fifteen substances in all. The 1971 Convention names thirteen barbiturates, read in the INCB Green List 36th edition of 2025 in this run: secobarbital in Schedule II at PS 001; amobarbital at PA 002, butalbital at PB 004, cyclobarbital at PC 001 and pentobarbital at PP 002 in Schedule III; and allobarbital at PA 005, barbital at PB 001, butobarbital at PB 005, methylphenobarbital at PM 008, phenobarbital at PP 008, secbutabarbital at PS 003 and vinylbital at PV 001 in Schedule IV. Matching was anchored at the start of the entry name, which is what keeps the longer names from being counted twice through the string barbital. Because the corpus offers no member row, the class is deferred rather than placed, and no single answer is given for it. The listing read is Anexo N. 2 of the Reglamento approved by Decreto Supremo 023-2001-SA, in the Catalogo de Sustancias Controladas published by the Direccion General de Medicamentos, Insumos y Drogas and marked NOVIEMBRE_2024_V1, which is the version this row was settled against as at 21 September 2026. Article 86 of Decreto Ley 22095 and the closing provisions of that Decreto Ley let the annexed lists be altered by Resolucion Suprema, so reading that version does not rule out a later list. This run, on 3 October 2026, searched an instrument the previous pass did not reach. Article 14.3 of Decreto Legislativo 1241, as replaced by article 2 of Decreto Legislativo 1592 published on 14 December 2023, provides that "La lista de Nuevas Sustancias Psicoactivas se aprueba mediante Resolución Ministerial del Ministerio del Interior" and that "Las actividades ilegales relacionadas con las citadas sustancias, se encuentran sancionadas". Resolucion Ministerial 0804-2026-IN of 17 June 2026, published in El Peruano on 18 June 2026, approves the "Lista de Nuevas Sustancias Psicoactivas (NSP)" as its annex, which runs to 736 numbered items followed by three named groups: alkyl nitrites, the genera of hallucinogenic mushrooms, and three plant species. Section I of the annex provides that the list "incluye sus análogos, sales, isómeros, ésteres, éteres, precursores, mezclas entre ellas o con otro tipo de sustancias, incluyendo los compuestos derivados", and it calls its detailed list its own Anexo 2; that is not Anexo N. 2 of the Reglamento, which is what Anexo N. 2 means everywhere in this cell. Its 736 numbered items and its closing groups were searched in Spanish, against the page images where the extracted text was doubtful, under barbital, barbitúrico and the names of the barbiturates Anexo N. 2 carries, and none of them is this substance. The annex names no barbiturate; the class remains carried in Anexo N. 2 by the members the previous pass listed, with no member row in this corpus. The annex also defines a nueva sustancia psicoactiva as any substance that produces a psychoactive effect by stimulating or depressing the central nervous system; that definition names no substance, and applying it to place this row would be an inference rather than a placement, so it is not applied. Both the Anexo N. 2 catalogue and the list of nuevas sustancias psicoactivas are read as at 3 October 2026, and article 14.3 of Decreto Legislativo 1241 lets the latter be updated by the same procedure that approved it, so this reading does not rule out a later list.
Confirm directly with Peru’s national drug authority or your own embassy before you rely on anything.
This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
